Rebecca Dabora
Technik-/Wissenschafts-/F&E-Leiter bei APOGEE THERAPEUTICS, INC.
Ursprung des Netzwerks ersten Grades von Rebecca Dabora
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 26 | |
Public Company | Biotechnology | 19 | |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA.
4
| Private Company | Biotechnology | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Rebecca Dabora
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Adimab LLC
Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | Biotechnology | Director/Board Member Chairman Director/Board Member Director/Board Member Corporate Officer/Principal | |
Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Sales & Marketing Chief Tech/Sci/R&D Officer | |
SPYRE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal General Counsel | |
PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Public Communications Contact Corporate Officer/Principal | |
BRIDGEBIO PHARMA, INC. | Biotechnology | Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal | |
FRACTYL HEALTH, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
X4 PHARMACEUTICALS, INC. | Biotechnology | Chairman Chief Executive Officer | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Tufts University | College/University | Undergraduate Degree Graduate Degree | |
The Johns Hopkins University | College/University | Corporate Officer/Principal Graduate Degree | |
ALECTOR, INC. | Biotechnology | Director/Board Member Founder | |
CARGO THERAPEUTICS, INC. | Biotechnology | Director/Board Member General Counsel | |
Stanford University | College/University | Doctorate Degree Doctorate Degree | |
Life Science Cares, Inc. | Director/Board Member Director/Board Member | ||
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
AKERO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Avitide, Inc.
Avitide, Inc. BiotechnologyHealth Technology Avitide, Inc. develops affinity purification solutions. Its technology enables development of chromatography resins via chemical synthesis which are not based on costly recombinant proteins. The company was founded by Errik B. Anderson, Warren Kett, Tillman U. Gerngross, Kevin Isett and Jonathan Sheller in 2012 and is headquartered in Lebanon, NH. | Biotechnology | Founder Director/Board Member | |
GlycoFi, Inc.
GlycoFi, Inc. BiotechnologyHealth Technology GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH. | Biotechnology | Director/Board Member Founder | |
IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Chief Administrative Officer | |
Ankyra Therapeutics, Inc.
Ankyra Therapeutics, Inc. Medical/Nursing ServicesHealth Services Ankyra Therapeutics, Inc. engages in the provision of healthcare services. The company is headquartered in Boston, MA. | Medical/Nursing Services | Founder Director/Board Member | |
QED Therapeutics, Inc.
QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., QED Therapeutics, Inc. is a biotechnology company based in Palo Alto, CA. The company focuses on precision medicine for FGFR-driven diseases and is committed to finding solutions to FGFR-driven cancers and diseases to give patients more possibilities. QED Therapeutics' lead investigational candidate is infigratinib, an orally administered, FGFR1-3 selective tyrosine kinase inhibitor that has shown activity in patients with chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions and advanced urothelial carcinoma with FGFR3 genomic alterations. In 2020, QED submitted a new drug application (NDA) with the Food and Drug Administration for second- and later-line cholangiocarcinoma. Michael Henderson has been the CEO of the company since 2017. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Origin Biosciences, Inc.
Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., Origin Biosciences, Inc. is an actively managed investment issuer focused on making equity investments in psychedelics industry-related companies to provide investors with diverse exposure to the sector. The company is based in Palo Alto, CA. The company, led by a team of industry experts, leverages its management expertise, professional network, and due diligence process to identify and invest in leading and emerging companies focused on the emerging psychedelics sector. Michael Henderson has been the CEO of the company since 2018. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Population Health Partners LLC
Population Health Partners LLC Investment ManagersFinance Population Health Partners LLC (Population Health Partners) is a private equity/venture capital founded in 2020 by Whit Bernard, Tamsin Berry, Chris Cox and Clive Meanwell. The firm is headquartered in San Francisco, California with an additional office in London. | Investment Managers | Founder Founder | |
Venrock Associates
Venrock Associates Investment ManagersFinance Venrock Associates is an Independent Venture Capital firm founded in 1969. The firm is headquartered in Palo Alto. | Investment Managers | Private Equity Investor Private Equity Investor | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO General Counsel | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree | |
Viridian LLC
Viridian LLC BiotechnologyHealth Technology Viridian LLC operates as a biopharmaceutical incubator. It focuses in the discovery and development of new molecular entities. The company was founded by Peter Harwin and Tomas Kiselak in 2016 and is headquartered in Philadelphia, PA. | Biotechnology | Founder Founder | |
VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Graduate Degree | |
PROMETHEUS BIOSCIENCES, INC. | Biotechnology | Investor Relations Contact Chief Executive Officer | |
Emory University | College/University | Graduate Degree Undergraduate Degree | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Bridger Management LLC
Bridger Management LLC Investment ManagersFinance Bridger Management LLC (Bridger) is a registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Roberto Mignone in 2000 and is a direct subsidiary of Bridger Management II LP. Bridger serves as the investment adviser, with discretionary trading authority, to private, pooled investment vehicles, the securities of which are offered through a private placement memorandum to accredited investors. | Investment Managers | Analyst-Equity | |
Helion Energy, Inc.
Helion Energy, Inc. Industrial MachineryProducer Manufacturing Helion Energy, Inc. manufactures power generation technology. It develops power plants that would produce electricity by running a nuclear-fusion reaction whereby atoms merge at extremely high temperatures. The company was founded by David Kirtley, John Slough, Chris Pihl and George Votroubek in 2009 and is headquartered in Redmond, WA. | Industrial Machinery | Director/Board Member | |
Oklo, Inc.
Oklo, Inc. Miscellaneous Commercial ServicesCommercial Services Oklo, Inc. constructs reactor and distributes power. The company was founded by Jacob DeWitte and Caroline Cochran and is headquartered in Mountain View, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Investment Managers | President |
Statistik
International
Vereinigte Staaten | 51 |
Sektoral
Health Technology | 31 |
Consumer Services | 11 |
Finance | 5 |
Commercial Services | 3 |
Health Services | 2 |
Operativ
Director/Board Member | 232 |
Corporate Officer/Principal | 98 |
Independent Dir/Board Member | 76 |
Undergraduate Degree | 45 |
Chief Executive Officer | 37 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Terry McGuire | 51 |
Ellen Marram | 33 |
Michael Wyzga | 31 |
Jane Henderson | 25 |
Ajay Royan | 24 |
Fred Driscoll | 21 |
Clive Meanwell | 21 |
Tomas Jan Heyman | 18 |
Halley Gilbert | 17 |
Thomas Anderson | 17 |
Howard Mayer | 16 |
Patrick C. Hutchison | 14 |
Michael Henderson | 14 |
William Jones | 14 |
Jennifer Fox | 13 |
- Börse
- Insiders
- Rebecca Dabora
- Unternehmensverbindungen